These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 2782977)
21. [Clinical and serological findings of giant-cell arteritis]. Vaith P; Warnatz K Z Rheumatol; 2009 Mar; 68(2):124-31. PubMed ID: 19159939 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778 [TBL] [Abstract][Full Text] [Related]
23. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Hazleman B Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S29-31. PubMed ID: 10948756 [TBL] [Abstract][Full Text] [Related]
24. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica. van Sleen Y; Boots AMH; Abdulahad WH; Bijzet J; Sandovici M; van der Geest KSM; Brouwer E Rheumatology (Oxford); 2020 Jan; 59(1):176-184. PubMed ID: 31292652 [TBL] [Abstract][Full Text] [Related]
26. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347 [TBL] [Abstract][Full Text] [Related]
27. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica. De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008 [TBL] [Abstract][Full Text] [Related]
28. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Federici AB; Fox RI; Espinoza LR; Zimmerman TS Arthritis Rheum; 1984 Sep; 27(9):1046-9. PubMed ID: 6332630 [TBL] [Abstract][Full Text] [Related]
29. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica. Hachulla E; Laine A; Hayem A Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887 [TBL] [Abstract][Full Text] [Related]
30. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Wise CM; Agudelo CA; Chmelewski WL; McKnight KM Arthritis Rheum; 1991 Dec; 34(12):1571-4. PubMed ID: 1747142 [TBL] [Abstract][Full Text] [Related]
31. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520 [TBL] [Abstract][Full Text] [Related]
32. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review]. Manganelli P; Mercadanti M; Nervetti A; Ambanelli U Minerva Med; 1987 Mar; 78(5):287-96. PubMed ID: 3822219 [TBL] [Abstract][Full Text] [Related]
33. Temporal arteritis presenting with paresis of the oculomotor nerve, and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate. Polák P; Pokorný V; Stvrtina S; Tauchmannova H; Malis F; Rovensky J J Clin Rheumatol; 2005 Aug; 11(4):242-4. PubMed ID: 16357769 [No Abstract] [Full Text] [Related]
34. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. González-Gay MA; García-Porrúa C; Vázquez-Caruncho M J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456 [TBL] [Abstract][Full Text] [Related]
35. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica. Papadakis MA; Schwartz ND Arch Intern Med; 1986 Nov; 146(11):2283-4. PubMed ID: 3778060 [TBL] [Abstract][Full Text] [Related]
36. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. Rynes RI; Mika P; Bartholomew LE Ann Rheum Dis; 1977 Feb; 36(1):88-90. PubMed ID: 843118 [TBL] [Abstract][Full Text] [Related]
37. Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis. Kyle V Baillieres Clin Rheumatol; 1991 Dec; 5(3):475-84. PubMed ID: 1807822 [TBL] [Abstract][Full Text] [Related]
38. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica. Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093 [TBL] [Abstract][Full Text] [Related]
39. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Myklebust G; Gran JT Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307 [TBL] [Abstract][Full Text] [Related]
40. Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval. Olsson AT; Elling H; Elling P Arthritis Rheum; 1997 Jan; 40(1):191-3. PubMed ID: 9008618 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]